{"nct_id":"NCT01518244","title":"Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America","status":"COMPLETED","status_verified_date":"2014-02","start_date":"2011-12","start_date_type":null,"primary_completion_date":"2013-02","primary_completion_date_type":"ACTUAL","completion_date":"2013-02","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["ALC"]}